Ken Griffin Organon & Co. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Organon & Co. stock. As of the latest transaction made, Citadel Advisors LLC holds 318,500 shares of OGN stock, worth $6.79 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
318,500
Previous 394,500
19.26%
Holding current value
$6.79 Million
Previous $5.69 Million
5.26%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding OGN
# of Institutions
785Shares Held
190MCall Options Held
2.46MPut Options Held
2.27M-
Black Rock Inc. New York, NY33.5MShares$715 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.8MShares$657 Million0.01% of portfolio
-
Massachusetts Financial Services CO Boston, MA10.2MShares$217 Million0.06% of portfolio
-
State Street Corp Boston, MA9.3MShares$198 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY5.15MShares$110 Million1.94% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $5.42B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...